Strategy Asset Managers’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$452K Sell
2,033
-4,095
-67% -$952K 0.07% 163
2026
Q2
$1.46M Buy
6,128
+28
+0.5% +$5.82K 0.22% 85
2026
Q1
$1.29M Buy
6,100
+1,159
+23% +$250K 0.21% 81
2025
Q4
$1.02M Buy
4,941
+6
+0.1% +$1.13K 0.17% 89
2025
Q3
$775K Buy
+4,935
New +$762K 0.14% 111
2024
Q3
– Sell
-9,434
Closed -$892K – 254
2024
Q2
$892K Buy
9,434
+2,352
+33% +$240K 0.2% 86
2024
Q1
$792K Buy
7,082
+220
+3% +$23.7K 0.17% 97
2023
Q4
$692K Sell
6,862
-805
-10% -$79.9K 0.16% 97
2023
Q3
$666K Sell
7,667
-1,767
-19% -$160K 0.17% 96
2023
Q2
$892K Buy
9,434
+627
+7% +$53K 0.2% 86
2023
Q1
$665K Buy
+8,807
New +$664K 0.16% 113

Other funds holding CAH

Strategy Asset Managers's CAH Position: Q3 2026 in Review

Strategy Asset Managers reduced its Cardinal Health (CAH) stake by 67% in Q3 2026, selling an estimated $952K and leaving 2,033 shares worth $452K. The position accounts for 0.07% of the portfolio, ranked #163.

Strategy Asset Managers first reported a position in CAH in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.46M in Q2 2026. 275 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Strategy Asset Managers held 2,033 shares of Cardinal Health worth $452K as of Q3 2026.
  • Strategy Asset Managers sold 4,095 Cardinal Health shares in Q3 2026, an estimated $952K.
  • Cardinal Health made up 0.07% of Strategy Asset Managers's portfolio in Q3 2026, its #163 holding.
  • Strategy Asset Managers first reported a position in Cardinal Health in Q1 2023 and has held it in 11 quarters since.
  • Strategy Asset Managers's Cardinal Health position peaked at $1.46M in Q2 2026.
  • 275 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Strategy Asset Managers's 13F filing for Q3 2026, filed 14 Oct 2026.